2018
DOI: 10.1016/j.clon.2018.01.009
|View full text |Cite
|
Sign up to set email alerts
|

Current Management of Intracranial Germ Cell Tumours

Abstract: Intracranial germ cell tumours (icGCTs) are uncommon tumours occurring in children and young adults. They are usually segregated into germinomas and non-germinomatous tumours (NGGCTs) in most classifications. Germinomas are highly curable tumours with multimodality treatment, but NGGCTs are associated with poorer survival outcomes. There are some differences in the approach to the management of icGCTs globally. Current research generally focuses on reducing treatment intensity, particularly the dose and volume… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
28
0
4

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(33 citation statements)
references
References 63 publications
1
28
0
4
Order By: Relevance
“…NGGCT still have good outcomes, with progression-free survival rates of 72% and 68%, and overall survival rates of 82% and 75%, for localised and metastatic patients, respectively, but require a more intensive combined chemoradiotherapy approach for cure than germinomas 12. While patients with metastatic NGGCT are treated with CSI, the radiotherapy management of localised NGGCT differ globally and varies from focal radiotherapy to CSI 13 14…”
Section: Introductionmentioning
confidence: 99%
“…NGGCT still have good outcomes, with progression-free survival rates of 72% and 68%, and overall survival rates of 82% and 75%, for localised and metastatic patients, respectively, but require a more intensive combined chemoradiotherapy approach for cure than germinomas 12. While patients with metastatic NGGCT are treated with CSI, the radiotherapy management of localised NGGCT differ globally and varies from focal radiotherapy to CSI 13 14…”
Section: Introductionmentioning
confidence: 99%
“…In some clinical trials, 50 IU/L of β-HCG was also used as a cut-off for germinoma patient recruitment [ 4 , 10 ]. However, patients with mild elevation of β-HCG only were just considered as “germinoma,” NGGCTs components, which were less sensitive to anti-tumor therapy, could not be ruled out completely [ 9 , 12 ]. As a result, it is problematic if hydrocephalus did not improve satisfactorily after full-dose chemotherapy delivering and surgical intervention was inevitable, especially during the peri-bone-marrow-suppression period.…”
Section: Discussionmentioning
confidence: 99%
“…CNS germinoma responds well to RT alone. Substantial late effects of irradiation especially in children and recent findings that reduced dosage of RT to primary site without prophylactic use of craniospinal RT (for localized tumors) can be effectively administered had led to attempts to reach an optimal reduced dosage for treating CNS germinoma [ 11 13 14 ]. Some clinical trials investigated the role of neoadjuvant chemotherapy in effectively reducing RT dose and volume, the results showed excellent progression-free survival [ 11 13 14 ].…”
Section: Discussionmentioning
confidence: 99%